Kancera AB (publ) (KAN) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.227x

Based on the latest financial reports, Kancera AB (publ) (KAN) has a cash flow conversion efficiency ratio of -0.227x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-9.80 Million ≈ $-1.05 Million USD) by net assets (Skr43.12 Million ≈ $4.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Kancera AB (publ) (KAN) balance sheet quality index to measure how much of total assets are equity-financed.

Kancera AB (publ) - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how Kancera AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Kancera AB (publ) (KAN) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Kancera AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kancera AB (publ) ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sabio Holdings Inc V:SBIO	-0.163x
CrownHaitai Holdings Co Ltd Preference Shares KO:005745	0.026x
Qiiwi Games AB (publ) ST:QIIWI	-0.078x
UTime Limited NASDAQ:WTO	0.019x
Superior Mining International Corp V:SUI	0.002x
EF EnergyFunders Ventures Inc V:EFV	0.007x
Autonomix Medical, Inc. Common Stock NASDAQ:AMIX	-0.491x
Fitell Corporation Ordinary Shares NASDAQ:FTEL	-0.030x

Annual Cash Flow Conversion Efficiency for Kancera AB (publ) (2010–2024)

The table below shows the annual cash flow conversion efficiency of Kancera AB (publ) from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see KAN market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr62.30 Million ≈ $6.70 Million	Skr-58.53 Million ≈ $-6.30 Million	-0.940x	+19.56%
2023-12-31	Skr47.66 Million ≈ $5.13 Million	Skr-55.67 Million ≈ $-5.99 Million	-1.168x	-162.54%
2022-12-31	Skr106.91 Million ≈ $11.51 Million	Skr-47.56 Million ≈ $-5.12 Million	-0.445x	-23.54%
2021-12-31	Skr122.54 Million ≈ $13.19 Million	Skr-44.12 Million ≈ $-4.75 Million	-0.360x	+43.47%
2020-12-31	Skr72.28 Million ≈ $7.78 Million	Skr-46.05 Million ≈ $-4.96 Million	-0.637x	+66.66%
2019-12-31	Skr17.42 Million ≈ $1.87 Million	Skr-33.29 Million ≈ $-3.58 Million	-1.911x	-41.51%
2018-12-31	Skr33.36 Million ≈ $3.59 Million	Skr-45.04 Million ≈ $-4.85 Million	-1.350x	+2.37%
2017-12-31	Skr38.71 Million ≈ $4.17 Million	Skr-53.54 Million ≈ $-5.76 Million	-1.383x	-256.36%
2016-12-31	Skr59.52 Million ≈ $6.41 Million	Skr-23.10 Million ≈ $-2.49 Million	-0.388x	+58.81%
2015-12-31	Skr21.93 Million ≈ $2.36 Million	Skr-20.66 Million ≈ $-2.22 Million	-0.942x	-34.58%
2014-12-31	Skr27.29 Million ≈ $2.94 Million	Skr-19.11 Million ≈ $-2.06 Million	-0.700x	-99.93%
2013-12-31	Skr18.96 Million ≈ $2.04 Million	Skr-6.64 Million ≈ $-714.35K	-0.350x	+92.89%
2012-12-31	Skr5.50 Million ≈ $591.78K	Skr-27.08 Million ≈ $-2.91 Million	-4.925x	-449.52%
2011-12-31	Skr25.90 Million ≈ $2.79 Million	Skr-23.21 Million ≈ $-2.50 Million	-0.896x	-75.76%
2010-12-31	Skr11.07 Million ≈ $1.19 Million	Skr-5.64 Million ≈ $-607.38K	-0.510x	--

About Kancera AB (publ)

ST:KAN Sweden Biotechnology

Market Cap

$1.98 Million

Skr18.44 Million SEK

Market Cap Rank

#29994 Global

#689 in Sweden

Share Price

Skr0.15

Change (1 day)

-23.82%

52-Week Range

Skr0.15 - Skr1.42

All Time High

Skr38.15